	Evaluating Clinically Significant Prostate Cancer with Pathology-Registered Radiomics: A Multi-Reader Assessment Using Lesion Diameter-based Simplified Segmentations on MRI. Acad Radiol Esengur OT, Harmon SA, Gelikman DG, Yilmaz EC, Zhang H, Simon B, An JY, Azamat S, Law YM, Margolis DJA, Marko J, Panebianco V, Merino MJ, Gurram S, Wood BJ, Lis R, Choyke PL, Pinto PA, Turkbey B. PMID: 42049617 [PubMed - as supplied by publisher]
	European Association of Urology Guidelines on Testicular Cancer: Summary of the 2026 Guidelines. Eur Urol Patrikidou A, Cazzaniga W, Oing C, Berney D, Lobo J, Boormans J, Fankhauser C, Fischer S, Leao R, Gravina C, Nardo DD, Cornes R, Janisch F, Bezuidenhout C, Haugnes HS, Papachristofilou A, Tandstad T, Heidenreich A. PMID: 42049597 [PubMed - as supplied by publisher]
	Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol Sherry AD, To V, D'souza C, Kiany S, Thio N, Liu S, Sun X, Castle B, Macdonald S, Choi H, Seo A, Hara K, Pryor D, Azad A, Tran B, Au L, Spain L, Ludmir EB, Jonasch E, Tannir NM, Msaouel P, Neeson P, Haymaker C, Tang C, Siva S. PMID: 42049596 [PubMed - as supplied by publisher]
	European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update. Eur Urol Parnham A, Albersen M, Ayres B, Crook J, Johnstone PAS, Oliveira P, Pagliaro LC, Pettaway C, Protzel C, Bryan Rumble R, Sánchez Martínez DF, Spiess PE, van der Heijden MS, Barreto L, Garcia-Perdomo HA, Greco I, Patterson K, Manzie K, Marcus JD, Osborne J, Bezuidenhout C, Tagawa S, Brouwer O. PMID: 42049595 [PubMed - as supplied by publisher]
	Reply to Ashwini Kadam, Ankit Misra and Gagan Prakash's Letter to the Editor Re: Chase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al. Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic Pathway. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.10.015. Eur Urol Ng CPY, Light A, Ahmed H, Shah T. PMID: 42049594 [PubMed - as supplied by publisher]
	Digital PCR-Based Uromonitor for Molecular Detection of Bladder Cancer: A Multicenter Validation Study Comparing Quantitative PCR and Urine Cytology. Clin Genitourin Cancer Kravchuk A, Garzaro JRR, Wirtz R, Wolff I, Koch S, Schlomm T, Rabien A, Meisl C, Rong D, Brás JP, Vinagre J, Otto T, Barski D, Gössl A, Siepmann S, Gilfrich C, Brookman-May S, Ecke T, May M. PMID: 42049549 [PubMed - as supplied by publisher]
	Older Age and Outcomes of Intravesical Bacillus Calmette-GuÃ©rin for Non-muscle-invasive Bladder Cancer. In Vivo Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T. PMID: 42049417 [PubMed - indexed for MEDLINE]
	Risk Factors and Clinical Significance of Grade â‰¥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer. In Vivo Sato R, Yoshimi Y, Nishio T, Matsunaga YU, Matsumoto R. PMID: 42049400 [PubMed - indexed for MEDLINE]
	Does Irradiation of Pelvic Lymph Nodes Have an Impact on the Bladder Filling Status in Patients With High-risk Prostate Cancer? In Vivo Rades D, Doehring L, Küter JD, Kristiansen C, Vestergård-Madsen C, Schulz CF, Janssen S. PMID: 42049398 [PubMed - indexed for MEDLINE]
	Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP Grade. Anticancer Res Hamada K, Yamasaki T, Ohe C, Tsujio N, Yamamoto S, Matsue T, Yukimatsu N, Otoshi T, Kato M, Kuratsukuri K, Shiohara M, Kohashi K, Uchida J. PMID: 42049363 [PubMed - indexed for MEDLINE]
	Early Progressive Disease Predicts Poor Outcomes of Second-line VEGFR Tyrosine Kinase Inhibitor Therapy After First-line Nivolumab Plus Ipilimumab in Advanced Renal Cell Carcinoma. Anticancer Res Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T. PMID: 42049357 [PubMed - indexed for MEDLINE]
	Real-world Delivery and Outcomes of Intravesical BCG for Non-muscle-invasive Bladder Cancer. Anticancer Res Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T. PMID: 42049353 [PubMed - indexed for MEDLINE]
	A Reminder App for Optimizing Bladder Filling During Radiotherapy for Prostate Cancer: A Pre-study in Healthy Volunteers. Anticancer Res Rades D, Narvaez-Wolf CA, Zwaan IC, Vestergård-Madsen C, Kristiansen C, Küter JD. PMID: 42049338 [PubMed - indexed for MEDLINE]
	Macroscopic Tumor Color as a Surrogate for Biological Diversity in Clear Cell Renal Cell Carcinoma. Anticancer Res Tsujio N, Ohe C, Shiohara M, Yukimatsu N, Yamasaki T, Kato M, Uno R, Uchida J, Kohashi K. PMID: 42049324 [PubMed - indexed for MEDLINE]
	(177)Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer. Radiology Ayati N, Papa N, Crumbaker M, Subramaniam S, Joshua AM, Alipour R, Iravani A, Askari E, Khan S, Yadav S, Eiber M, Weickhardt A, Lee ST, Ng S, Francis RJ, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Nguyen A, Hofman MS, Sandhu S, Hioki T, van Oorschodt JCJ, Devitt K, Willowson K, Sharma S, Stancu A, Chauvie S, Wilson P, Martin AJ, Thomas H, Stockler MR, Davis ID, Emmett L, Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group. PMID: 42048586 [PubMed - indexed for MEDLINE]
	Routine Retrograde Conduitography after Radical Cystectomy for Bladder Cancer: Diagnostic Yield and Clinical Impact. Urol Int Scheper V, Berninger L, Schwinger M, Woidich R, Egenolf T, Däuwel M, Hahn O, Seitz AK, Kübler H, Kalogirou C. PMID: 42048277 [PubMed - as supplied by publisher]
	Metformin in prostate cancer: a context-dependent antitumour strategy driven by metabolic vulnerability and signalling network. Discov Oncol Yan L, Chen D, Wu T, Zhao J, Xu X, Xu W, Zhang H, Xiao M. PMID: 42047898 [PubMed - as supplied by publisher]
	Active surveillance for renal masses up to 2Â cm: long-term oncological outcomes from a prospective multi-institutional study. World J Urol Re C, Bertini A, Scilipoti P, Saccucci T, Mantica G, Cazzaniga W, Matloob R, Conti G, Maccagnano C, Furlan M, Suardi N, Simeone C, Montanari E, Albo G, Stagni S, Salvioni R, Castiglione F, Larcher A, Rosiello G, Terrone C, Montorsi F, Salonia A, Capitanio U, Bertini R. PMID: 42047824 [PubMed - indexed for MEDLINE]
	Prostate cancer cells' growth is decreased by novel MYC inhibitors. Invest New Drugs Nickkholgh B, McGrath J, Sittadjody S, Chauhan J, Fletcher S, Balaji KC. PMID: 42047739 [PubMed - as supplied by publisher]
	Rewired lipid metabolism in castration-resistant prostate cancer: molecular interplay between glucose metabolism and sterol synthesis. Mol Biol Rep K B HP, Arockiasamy S, Krishnamoorthy S. PMID: 42047726 [PubMed - in process]

Articles 1 - 20 / 177825

Page 1 of 8892



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy